Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Agenus Inc.

TRADE

NASDAQ: AGENHealthcare / Biotechnology / USA
1.96-0.04-2.00%Vol 1 137 5751Y Perf -55.93%
Oct 19th, 2018 16:00
BID1.96 ASK1.97
Open2.00 Previous Close2.00
Pre-Market2.10 After-Trading1.97
 0.10 5.00%  0.01 0.51%
Target Price
7.00 
Analyst Rating
Strong Buy 1.00
Potencial %
257.14 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/9 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/83 
Growth Ranking
★★+     47.97
Insiders Shares Cnt. % 3/6/12M
-/-/83 
Income Ranking
 —    -
Market Cap (mil)222 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
8.84 
Earnings Date
6th Nov 2018

Today's Price Range

1.922.06

 

52wk Range

1.556.19

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-6.67%
3 Months
-7.55%
6 Months
-48.15%
1 Year
-55.93%
3 Years
-57.48%
5 Years
-27.41%

Quotes

Name / TickerPriceChg.Chg.%
AGEN1.96-0.0400-2.00
AAPL219.313.29001.52
GOOG1 096.468.49000.78
MSFT108.660.16000.15
XOM81.970.12000.15
WFC52.89-0.2100-0.40
JNJ139.05-0.4500-0.32
FB154.05-0.8700-0.56
GE12.560.18001.45
JPM107.91-0.1800-0.17
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.10
Current Ratio 1.30
Long Term Debt to Total Capital 0.94
Total Debt to Equity 15.08
Interest Coverage -
Leverage Ratio -1.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-421.20
EBITDA Margin-400.40
Pre-tax Profit Margin-563.30
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 49.72
PS Ratios 10.80
Price to Cash Flow 113.40
Price to Free Cash Flow -2.20
Cash Flow Per Share -1.20
Price to Tangible Book-1.48
Book Value per Share-0.99
Enterprise Value (in ths.)190 790
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-10 718.30
ROE last 12 Months 231.10
Return on Assets (5Y Avg) -54.18
ROA last 12 Months -96.59
Return on Capital (5Y Avg) -
ROC last 12 Months -73.55
Return on invested Capital Q -
Return on invested Capital Y-91.92
Assets Turnover0.10
Receivables Turnover1.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)20 463
Revenue per Share 0.18
Revenue Growth 3 Years 11.10
Revenue Growth 5 Years 60.69
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.38-0.2436.84
Q01 2018-0.28-0.42-50.00
Q04 2017-0.28-0.35-25.00
Q03 2017-0.37-0.370.00
Q02 2017-0.36-0.3211.11
Q01 2017-0.32-0.1843.75
Q04 2016-0.33-0.309.09
Q03 2016-0.32-0.47-46.88
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.2532.43Positive
12/2018 QR-0.2923.68Positive
12/2018 FY-1.2022.08Positive
12/2019 FY-1.464.58Positive
Next Report Date6th Nov 2018
Estimated EPS Next Report-0.25
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1 137 575
Shares Outstanding (in ths.)113 280
Trades Count2 871
Dollar Volume2 198 832
Avg. Volume1 486 002
Avg. Weekly Volume1 013 071
Avg. Monthly Volume1 199 778
Avg. Quarterly Volume1 338 616

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

39%61%

Bearish Bullish

69%31%

Bearish Bullish

46%54%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x